David Apelian serves as Executive at ACHILLION PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, David Apelian has executed 6 insider transactions totaling $154.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 16, 2022 involved selling 5,000 shares valued at $49.0K.
David Apelian currently holds 11,000 shares of ACHILLION PHARMACEUTICALS INC (ACHN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Apelian has been a net seller of ACHN stock. They have purchased $0 and sold $154.1K worth of shares.
David Apelian's most recent insider trade was on Aug 16, 2022, when they sold 5,000 shares at $9.81 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 12, 2021 | EIGR | $0 | Award | 5,000 | $N/A | Discretionary |
| Mar 12, 2020 | EIGR | $0 | Award | 5,000 | $N/A | Discretionary |
| Dec 30, 2015 | ACHN | $30.2K | Option Exercise | 10,000 | $3.02 | Discretionary |
| Dec 30, 2015 | ACHN | $105.0K | Sale | 10,000 | $10.50 | Discretionary |